Moderate to severe mitral insufficiency (MI) importantly affects short-term survival in patients with dilated cardiomyopathy (DCM). Heart transplantation (HTX) represents first-choice therapy, but is the least available therapeutic option. Restrictive mitral valve anuloplasty (RMV) is possibly an alternative strategy. Material and methods: Since 1998, 11 (7/11 male, age 62±6 years) patients with DCM/IM underwent RMV at our Institution. Etiology was idiopathic in 5 patients and post-ischemic in 6. NYHA functional class was III in 2, IV in 9 cases; preoperative assisted ventilation was necessary in 2 patients. Two patients were awaiting for a donor heart, 3 had contraindications for HTX. Left ventricular enddiastolic volume (EDV) and ejection fraction (EF) were 232 6 35 ml and 0.24±0.04 respectively. Preoperative treatment included inotropic support with dopamine (6 mcg/Kg/min) and no reduction of ACE-inhibitors in all patients; mechanical support with intraaortic counterpulsation (IABP) was started before operation in 4 patients. RMV included implantation of a rigid ring (Baxter Carpentier-Edwards Classic); mean undersizing was 4.8 6 2.1. Three patients underwent associated left ventriculoplasty with an original approach. Coronary bypass was performed in 3 cases. Cold blood cardioplegia with normothermic induction was used in all patients. Results: There was 1 hospital death. Mean duration of assisted ventilation was 3.1±3.4 days. Catecholamine support was 8±6.6 days. Nine patients were supported with IABP (1.2±0.9 days). Delayed sternal closure was used in 1 case. Pre discharge EDV and EF were respectively 189 6 32 ml and 0.32±0.07 (p<0.001). At a 9.3-month mean follow-up, 9 patients are in I–II NYHA class and 1 is awaiting for HTX. Conclusions: RMV may represent a relatively low-risk surgical alternative or bridge to HTX in some patients. Optimal patients’ selection and medium-to-long term result are unknown.

Restrictive mitral valve anuloplasty in dilated cardiomyopathy / F. Donatelli, A. Moneta, G. Marchetto, M. Pocar, M. Triggiani, E. Villa, A. Grossi. - In: CARDIOVASCULAR SURGERY. - ISSN 0967-2109. - 8:suppl. 1(2000 Jun), pp. 17-17. ((Intervento presentato al 49. convegno International Congress of the European Society for Cardiovascular Surgery tenutosi a Dresden nel 2000.

Restrictive mitral valve anuloplasty in dilated cardiomyopathy

F. Donatelli
Primo
;
G. Marchetto;M. Pocar;E. Villa
Penultimo
;
A. Grossi
Ultimo
2000-06

Abstract

Moderate to severe mitral insufficiency (MI) importantly affects short-term survival in patients with dilated cardiomyopathy (DCM). Heart transplantation (HTX) represents first-choice therapy, but is the least available therapeutic option. Restrictive mitral valve anuloplasty (RMV) is possibly an alternative strategy. Material and methods: Since 1998, 11 (7/11 male, age 62±6 years) patients with DCM/IM underwent RMV at our Institution. Etiology was idiopathic in 5 patients and post-ischemic in 6. NYHA functional class was III in 2, IV in 9 cases; preoperative assisted ventilation was necessary in 2 patients. Two patients were awaiting for a donor heart, 3 had contraindications for HTX. Left ventricular enddiastolic volume (EDV) and ejection fraction (EF) were 232 6 35 ml and 0.24±0.04 respectively. Preoperative treatment included inotropic support with dopamine (6 mcg/Kg/min) and no reduction of ACE-inhibitors in all patients; mechanical support with intraaortic counterpulsation (IABP) was started before operation in 4 patients. RMV included implantation of a rigid ring (Baxter Carpentier-Edwards Classic); mean undersizing was 4.8 6 2.1. Three patients underwent associated left ventriculoplasty with an original approach. Coronary bypass was performed in 3 cases. Cold blood cardioplegia with normothermic induction was used in all patients. Results: There was 1 hospital death. Mean duration of assisted ventilation was 3.1±3.4 days. Catecholamine support was 8±6.6 days. Nine patients were supported with IABP (1.2±0.9 days). Delayed sternal closure was used in 1 case. Pre discharge EDV and EF were respectively 189 6 32 ml and 0.32±0.07 (p<0.001). At a 9.3-month mean follow-up, 9 patients are in I–II NYHA class and 1 is awaiting for HTX. Conclusions: RMV may represent a relatively low-risk surgical alternative or bridge to HTX in some patients. Optimal patients’ selection and medium-to-long term result are unknown.
Settore MED/23 - Chirurgia Cardiaca
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
European Society for Cardiovascular Surgery
Article (author)
File in questo prodotto:
File Dimensione Formato  
2000 CVS-ESCVS Dresden.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 418.96 kB
Formato Adobe PDF
418.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/203961
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact